| publication name | Looking at data of clinical trials |
|---|---|
| Authors | Bendary A |
| year | 2017 |
| keywords | Trials; Data; Interpretation |
| journal | J Heart Health Cir |
| volume | 1 |
| issue | 1 |
| pages | Not Available |
| publisher | iMedpub journals |
| Local/International | International |
| Paper Link | http://www.imedpub.com/articles/looking-at-data-of-clinical-trials.pdf |
| Full paper | download |
| Supplementary materials | Not Available |
Abstract
My father once told me when I was a child:“if you believe all what you read, do not read!” Later on, I realized that this's true, especially in the era of evidence based medicine. Recently, data fabrication has emerged as a nail in a coffin for clinical trials [1]. There is a natural tendency to assess the results of randomized clinical trials as either positive or negative according to whether the P value for the primary outcome measure is< 0.05 or> 0.05. However, such an interpretation is overly simplistic